Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
FIVE PRIME THERAPEUTICS, INC. (FPRX)
Sector: Healthcare; Industry: Biotechnology

Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of innovative protein therapeutics. The company's product candidates comprise Bemarituzumab, an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, which is in Phase 3 clinical trials to treat patients with gastric or gastroesophageal junction and GEJ cancer; and FPA150, a CD8 T cell checkpoint inhibitor antibody that is in Phase 1a/1b clinical trial that targets B7-H4 in various cancers, as well as FPT155, a soluble CD80 fusion protein, which is in Phase 1a/1b clinical trial that enhances co-stimulation of T cells through CD28. The company was founded in 2001 and is headquartered in South San Francisco, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-11-11 BVF PARTNERS L P/IL nan Sell 7,393,340 $20.19 $149,247,137 No
2020-11-11 RINGO WILLIAM R Director Sell 78,959 $22.50 $1,776,578 Yes
2020-11-06 BVF PARTNERS L P/IL 10%-Owner Buy 446,562 $4.89 $2,184,092 No
2020-10-06 BVF PARTNERS L P/IL 10%-Owner Buy 345,241 $5.04 $1,738,288 No
2020-09-22 BVF PARTNERS L P/IL 10%-Owner Buy 32 $3.80 $122 No
2020-05-14 BVF PARTNERS L P/IL 10%-Owner Buy 293,587 $4.10 $1,203,707 No
2019-12-20 BVF PARTNERS L P/IL 10%-Owner Buy 515,020 $4.05 $2,085,831 No
2019-12-09 BVF PARTNERS L P/IL 10%-Owner Buy 135,000 $4.02 $542,362 No
2019-12-03 BERGER FRANKLIN M Director Sell 79,980 $3.97 $317,353 No
2019-11-22 BVF PARTNERS L P/IL 10%-Owner Buy 1,120,010 $3.40 $3,808,146 No
2019-11-05 BVF PARTNERS L P/IL 10%-Owner Buy 968,112 $4.00 $3,872,448 No
2019-10-31 BVF PARTNERS L P/IL 10%-Owner Buy 29,314 $3.88 $113,814 No
2019-10-25 BVF PARTNERS L P/IL 10%-Owner Buy 169,370 $3.75 $634,322 No
2019-10-08 BVF PARTNERS L P/IL 10%-Owner Buy 601,482 $3.74 $2,250,962 No
2017-11-01 RINGO WILLIAM R Director Sell 600 $45.33 $27,198 Yes
2017-10-02 RINGO WILLIAM R Director Sell 1,800 $40.26 $72,468 Yes
2017-09-28 RINGO WILLIAM R Director Sell 2,000 $38.00 $76,000 Yes
2017-03-01 RINGO WILLIAM R Director Sell 500 $46.73 $23,365 Yes
2017-02-01 RINGO WILLIAM R Director Sell 500 $46.17 $23,085 Yes
2017-01-18 Sarena Francis Willard Chief Strategy Officer Sell 3,636 $47.39 $172,310 Yes
2017-01-03 RINGO WILLIAM R Director Sell 500 $51.07 $25,535 Yes
2016-12-23 Williams Lewis T President, CEO and Chairman Sell 30,000 $50.50 $1,514,859 Yes
2016-12-01 RINGO WILLIAM R Director Sell 500 $57.72 $28,860 Yes
2016-11-28 Sarena Francis Willard Chief Strategy Officer Sell 1,710 $60.14 $102,839 Yes
2016-11-25 Sarena Francis Willard Chief Strategy Officer Sell 34,654 $60.38 $2,092,508 Yes
2016-11-09 Jensen Peder Director Sell 8,130 $55.30 $449,589 Yes
2016-11-01 RINGO WILLIAM R Director Sell 500 $48.67 $24,335 Yes
2016-10-03 RINGO WILLIAM R Director Sell 500 $52.00 $26,000 Yes
2016-09-01 RINGO WILLIAM R Director Sell 500 $44.20 $22,100 Yes
2016-08-01 RINGO WILLIAM R Director Sell 500 $50.77 $25,385 Yes

Insider Smart

Camping World Holdings, Inc (CWH) - Another crash victim, Camping World Holdings, Inc took a deep dive from $16 to $4, several insiders bought around $6. With insiders on your side, this would be an easy add and hold to get your cost under $6. A 300% gain because stock is about to breach $25 in the coming weeks.

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.